Roche proposes former Takeda CEO for board seat
23/09/2026 06:09
Roche proposes former Takeda CEO for board seat ZURICH, Sept 23 (Reuters) - Roche ROPC.S on Wednesday said it was proposing Christoph Weber, the former CEO of Takeda Pharmaceuticals 4502.T, for election to the Swiss company's board of directors at its AGM next March.
"Christophe's intimate knowledge of the healthcare industry and his broad leadership experience will further strengthen our Board," said Roche Chairman Severin Schwan in a statement.
(Reporting by John Revill
Editing by Linda Pasquini)((John.Revill@thomsonreuters.com; +41 41 528 36 37; Reuters Messaging: john.revill.thomsonreuters.com@reuters.net))
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)